Evaluation of Beta-Adrenergic Function in Normal and Asthmatic Children

References

• Szentivanyi A. The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 1968; 42: 203, 228
   Google Scholar
• Cookson D U., Reed C E. A comparison of the effects of isoproterenol in the normal and asthmatic subjects. Am Rev Respir Dis 1963; 88: 636, 643
   PubMedGoogle Scholar
• Szentivanyi A, Fishel C W., Talmage D W. Adrenaline mediation of histamine and serotonin hyperglycemia in normal mice and the absence of adrenalin-induced hyperglycemia in pertussis-sensitized mice. J Infect Dis 1963; 113: 86, 98
   PubMed Web of Science ®Google Scholar
• Fishel C W., Szentivanyi A. The absence of adrenaline-induced hyperglycemia in pertussis-sensitized mice and its relation on histamine and serotonin hypersensitivity. J Allergy 1963; 34: 439, 454
   PubMedGoogle Scholar
• Inoue S. Effects of epinephrine on asthmatic children. J Allergy 1967; 40: 337, 348
   PubMedGoogle Scholar
• Lockey S D., Glennon J A., Reed C E. Comparison of some metabolic responses in normal and asthmatic subjects to epinephrine and glucagon. J Allergy 1967; 40: 349, 354
   PubMedGoogle Scholar
• Kirkpatrick C H., Keller C. Impaired responsiveness to epinephrine in asthma. Am Rev Respir Dis 1967; 96: 692, 699
   PubMedGoogle Scholar
• Grieco M H., Pierson R N., Pi-Sunyer F X. Comparison of the circulatory and metabolic effects of isoproterenol, epinephrine and methoxamine in normal and asthmatics subjects. Am J Med 1968; 44: 863, 872
   PubMed Web of Science ®Google Scholar
• Middleton E, Finke S R. Metabolic response to epinephrine in bronchial asthma. J Allergy 1968; 42: 288, 299
   PubMedGoogle Scholar
• Leeks H I., Wood D W., Donsky G. The metabolic, circulatory, andbronchomotor responses of asthmatic children to epinephrine infusion: Pharmacologic effects. J Allergy 1969; 44: 261, 271
   PubMedGoogle Scholar
• Fireman P, Palm C R., Friday G A., Drash A L. Metabolic responses to epinephrine in asthmatic, eczematous, and normal subjects. J Allergy 1970; 45: 117
   Google Scholar
• Maselli R, Meltzer E O., Ellis E F. Pharmacologic effects of epinephrine in asthmatic children. J Allergy 1970; 45: 117
   Google Scholar
• Reed C E., Cohen M, Enta T. Reduced effect of epinephrine on circulating eosinophils in asthma and after beta-adrenergic blockade or Bordetella pertussis vaccine. J Allergy 1970; 46: 90, 102
   PubMedGoogle Scholar
• Makino S, Quelette J, Reed C E., Fishel C. Correlation between increased bronchial response to acetylcholine and diminished metabolic and eosinopenic responses to epinephrine in asthma. J Allergy 1970; 46: 178, 189
   PubMedGoogle Scholar
• Fireman P. Metabolic abnormalities in asthma-decreased urinary cyclic AMP. Int Arch Allergy 1973; 45: 123, 127
   Web of Science ®Google Scholar
• Jenne J W., Chick T W., Strickland R D., Wall F J. A Comparison of beta adrenergic function in asthma and chronic bronchitis. J Allergy Clin Immunol 1977; 60: 346, 356
   PubMed Web of Science ®Google Scholar
• Schwartz H J., White L W. Urinary and plasma cyclic AMP responses to epinephrine in asthmatic and normal subjects. J Allergy Clin Immunol 1973; 51: 88, 89
   Web of Science ®Google Scholar
• Apold J, Aksnes L. Correlation between increased bronchial responsiveness to histamine and diminished plasma cyclic adenosine monophosphate response after epinephrine in asthmatic children. J Allergy Clin Immunol 1977; 59: 343, 347
   PubMed Web of Science ®Google Scholar
• Raij K, Alanko K, Muittari A, Harkonen M. Effect of salbutamol inhalations on plasma and urinary cyclic adenosine monophosphate levels in asthmatics and non-atopic controls. Scand J Resp Dis 1976; 57: 223, 230
   PubMedGoogle Scholar
• Krzanowsky J J., Poison J B., Goldman A L., Ebel T, Szentivanyi A. Reduced adenosine 3′, 5′-cyclic monophosphate levels in patients with reversible obstructive airways disease. Clin Exp Pharmacol Physiol 1979; 6: 11, 15
   PubMed Web of Science ®Google Scholar
• Shelhamer J H., Metcalfe D, Smith L J., Kaliner M. Abnormal beta adrenergic responsiveness in allergic subjects: analysis of isoproterenol-induced cardiovascular and plasma cyclic adenosine monophosphate responses. J Allergy Clin Immunol 1980; 66: 52, 60
   PubMed Web of Science ®Google Scholar
• Nelson H S. The effect of ephedrine on the response to epinephrine in normal men. J Allergy Clin Immunol 1973; 51: 191, 198
   PubMed Web of Science ®Google Scholar
• Morris H G., Rusnak S A., Seiner J C., Barzens K, Barnes J. Comparative effects of ephedrine on adrenergic responsiveness in normal and asthmatic subjects. J Allergy Clin Immunol 1978; 61: 294, 302
   PubMed Web of Science ®Google Scholar
• Bernstein R A., Linarelli L, Friday G A., Drash A, Fireman P. Effect of ephedrine sulfate on urinary cyclic adenosine monophosphate. J Allergy Clin Immunol 1973; 51: 89
   Web of Science ®Google Scholar
• Kaliner M, Shelhamer J H., Davis P B., Smith L J., Venter J C. Autonomic nervous system abnormalities and allergy. Ann Intern Med 1982; 96: 249, 257
   Web of Science ®Google Scholar
• Davis P B., Simpson D M., Paget G L., Turi V. Beta adrenergic responses in drug-free subjects with asthma. J Allergy Clin Immunol 1986; 77: 871, 879
   PubMed Web of Science ®Google Scholar
• Abramson E, Arky R. Role of beta adrenergic receptors in counterregulation of insulin-induced hypoglycemia. Diabetes 1968; 17: 141, 146
   PubMed Web of Science ®Google Scholar
• Exton J K., Paker C R. The role of cyclic AMP in the control of liver metabolism. Adv Enzym Reg 1968; 6: 391, 407
   PubMedGoogle Scholar
• Sloan I, Sawh P, Bihler I. Influence of adrenaline on sugar transport in soleus, and skeletal muscle. Mol Cell Endocr 1978; 10: 3, 12
   PubMed Web of Science ®Google Scholar
• Deibert D, Defronzo R. Epinephrine-induced insulin resistence in man. Clin Res 1979; 27: 365
   Google Scholar
• Rizza R A., Cryer P E., Haymond M W., Gerich J E. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 1980; 65
   Web of Science ®Google Scholar
• Gerich J E., Lorenzi M, Tsalikian E, Karan J H. Studies on the mechanism of epinephrine-induced hyperglycemia in man: Evidence for participation of pancreatic glucagon secretion. Diabetes 1976; 25
   Web of Science ®Google Scholar
• Rizza R A., Cryer P E., Gerich J E. Role of glucagon, cathecolamines, and hormone in human glucose counterregulation. J Clin Invest 1979; 64: 62, 71
   PubMed Web of Science ®Google Scholar
• Rizza R A., Haymond M, Cryer P, Gerich J. Differential effects of epinephrine on glucose production and disposal in man. Am J Physiol 1979; 237: E356–E362
   PubMedGoogle Scholar
• Rosen S G., Clutter W E., Berk M A., Shan S D., Cryer P E. Epinephrine supports the post absorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man. J Clin Invest 1984; 73: 405, 411
   PubMed Web of Science ®Google Scholar
• Minneman K P., Hegstrand L R., Molinoff P B. Simultaneous determination of beta-1 and beta-2 adrenergic receptors in tissues containing both receptor subtype. Mol Pharmacol 1979; 25: 286, 298
   Google Scholar
• Pearlman D S., Bierman C W. Asthma (bronchial asthma, reactive airways disorder). Allergic Diseases of Infancy, Children and Adolescence, C W Bierman, D S Pearlman. WB Saunders Co., Philadelphia 1980; 581
   Google Scholar
• Kingsley G R., Getchell G. Direct ultramicro glucose oxidase method for determination of glucose in biologic fluids. Clin Chem 1960; 6: 466, 475
   PubMed Web of Science ®Google Scholar
• Siegel S. Estadistica no parametrica aplicada a las ciéncias de la conduta. Trillas, México 1975; 346
   Google Scholar
• Hollander M, Wolpe D A. Nonparametric Statistical Methods. Wiley & Sons, New York 1973; 503
   Google Scholar
• Galant S P., Duriseti L, Underwood S, Insel P A. Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. N Engl J Med 1978; 229: 933, 936
   Google Scholar